Gene description for MYOF |
Gene name |
myoferlin |
Gene symbol |
MYOF |
Other names/aliases |
FER1L3 HAE7 |
Species |
Homo sapiens |
Experiment description of studies that identified MYOF in Prostate cancer cells |
1
|
Experiment ID | 963 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
25844599
|
Organism | Homo sapiens |
Experiment description | Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors | Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, UlléA, Yachnin J, Nilsson S, Panaretakis T. |
Journal name |
Oncotarget
|
Publication year | 2015 |
Sample | Prostate cancer cells |
Sample name | DU145 Tax-Sen |
Isolation/purification methods | Differential centrifugation Ultracentrifugation Density gradient centrifugation |
Flotation density | 1.12-1.19 g/mL |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry Western blotting |
EV-TRACK |
EV150027: EV-METRIC:11%, 56%
|
|
|
2
|
Experiment ID | 964 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
25844599
|
Organism | Homo sapiens |
Experiment description | Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors | Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, UlléA, Yachnin J, Nilsson S, Panaretakis T. |
Journal name |
Oncotarget
|
Publication year | 2015 |
Sample | Prostate cancer cells |
Sample name | DU145 Tax-Res |
Isolation/purification methods | Differential centrifugation Ultracentrifugation Density gradient centrifugation |
Flotation density | 1.13-1.18 g/mL |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry Western blotting |
EV-TRACK |
EV150027: EV-METRIC:11%, 56%
|
|
|
3
|
Experiment ID | 1260 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
24371517
|
Organism | Homo sapiens |
Experiment description | Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients. |
Authors | Bijnsdorp IV, Geldof AA, Lavaei M, Piersma SR, van Moorselaar RJ, Jimenez CR. |
Journal name |
J Extracell Vesicles.
|
Publication year | 2013 |
Sample | Prostate cancer cells |
Sample name | LNCaP |
Isolation/purification methods | Differential centrifugation Ultracentrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry Western blotting |
EV-TRACK |
EV130168: EV-METRIC:11%, 11%
|
|
|
4
|
Experiment ID | 1261 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
24371517
|
Organism | Homo sapiens |
Experiment description | Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients. |
Authors | Bijnsdorp IV, Geldof AA, Lavaei M, Piersma SR, van Moorselaar RJ, Jimenez CR. |
Journal name |
J Extracell Vesicles.
|
Publication year | 2013 |
Sample | Prostate cancer cells |
Sample name | PC3 |
Isolation/purification methods | Differential centrifugation Ultracentrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry Western blotting |
EV-TRACK |
EV130168: EV-METRIC:11%, 11%
|
|
|